-
1
-
-
45149115634
-
Propranolol for severe hemangiomas of infancy
-
C. Léauté-Labrèze, E. Dumas de la Roque, T. Hubiche, F. Boralevi, J.B. Thambo, and A. Taïeb Propranolol for severe hemangiomas of infancy N Engl J Med 358 2008 2649 2651
-
(2008)
N Engl J Med
, vol.358
, pp. 2649-2651
-
-
Léauté-Labrèze, C.1
Dumas De La Roque, E.2
Hubiche, T.3
Boralevi, F.4
Thambo, J.B.5
Taïeb, A.6
-
2
-
-
81255136219
-
Propranolol therapy in 55 infants with infantile hemangioma: Dosage, duration, adverse effects, and outcome
-
C.J. Schupp, J.B. Kleber, P. Günther, and S. Holland-Cunz Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome Pediatr Dermatol 28 2011 640 644
-
(2011)
Pediatr Dermatol
, vol.28
, pp. 640-644
-
-
Schupp, C.J.1
Kleber, J.B.2
Günther, P.3
Holland-Cunz, S.4
-
3
-
-
84859108637
-
Topical propranolol therapy for infantile hemangiomas
-
K. Kunzi-Rapp Topical propranolol therapy for infantile hemangiomas Pediatr Dermatol 29 2012 154 159
-
(2012)
Pediatr Dermatol
, vol.29
, pp. 154-159
-
-
Kunzi-Rapp, K.1
-
5
-
-
84856201139
-
Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: A retrospective, multicenter, cohort study
-
A. Chakkittakandiyil, R. Phillips, I.J. Frieden, E. Siegfried, I. Lara-Corrales, and J. Lam Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study Pediatr Dermatol 29 2012 28 31
-
(2012)
Pediatr Dermatol
, vol.29
, pp. 28-31
-
-
Chakkittakandiyil, A.1
Phillips, R.2
Frieden, I.J.3
Siegfried, E.4
Lara-Corrales, I.5
Lam, J.6
-
6
-
-
84874938491
-
Topical timolol for small hemangiomas of infancy
-
M. Moehrle, C. Léauté-Labrèze, V. Schmidt, M. Röcken, C.F. Poets, and R. Goelz Topical timolol for small hemangiomas of infancy Pediatr Dermatol 30 2013 245 249
-
(2013)
Pediatr Dermatol
, vol.30
, pp. 245-249
-
-
Moehrle, M.1
Léauté-Labrèze, C.2
Schmidt, V.3
Röcken, M.4
Poets, C.F.5
Goelz, R.6
-
7
-
-
0020264080
-
Timolol and propranolol: Bioavailability, plasma concentrations, and beta blockade
-
T.W. Wilson, W.B. Firor, G.E. Johnson, G.I. Holmes, M.C. Tsianco, and P.B. Huber Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade Clin Pharmacol Ther 32 1982 676 685
-
(1982)
Clin Pharmacol Ther
, vol.32
, pp. 676-685
-
-
Wilson, T.W.1
Firor, W.B.2
Johnson, G.E.3
Holmes, G.I.4
Tsianco, M.C.5
Huber, P.B.6
-
8
-
-
84878875115
-
Evaluation of skin permeation of β-blockers for topical drug delivery
-
D. Chantasart, J. Hao, and S.K. Li Evaluation of skin permeation of β-blockers for topical drug delivery Pharm Res 30 2013 866 877
-
(2013)
Pharm Res
, vol.30
, pp. 866-877
-
-
Chantasart, D.1
Hao, J.2
Li, S.K.3
-
9
-
-
0027365445
-
Metabolism of propranolol during percutaneous absorption in human skin
-
J.I. Ademola, C.A. Chow, R.C. Wester, and H.I. Maibach Metabolism of propranolol during percutaneous absorption in human skin J Pharm Sci 82 1993 767 770
-
(1993)
J Pharm Sci
, vol.82
, pp. 767-770
-
-
Ademola, J.I.1
Chow, C.A.2
Wester, R.C.3
Maibach, H.I.4
-
10
-
-
77954867089
-
Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action
-
C.H. Storch, and P.H. Hoeger Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action Br J Dermatol 163 2010 269 274
-
(2010)
Br J Dermatol
, vol.163
, pp. 269-274
-
-
Storch, C.H.1
Hoeger, P.H.2
|